In response to the urgent need for antiviral treatments, we are identifying existing drugs that may work against COVID-19.
Our team, including Drs.Roberto Botelho, Michael Olson, Sarah Sabatinos, Raffi Karshafian,Joe McPhee, postdoctoral fellow Dr. Michael Sugiyama and partner Cyclica Inc., is using artificial intelligence to identify known drugs that may have new actions against the virus.
We're also investigating the effectiveness of ultrasound and microbubbles therapy in impeding infection, in partnership with MD Precision.
Dr. Costin N. Antonescu
Associate Professor
Department of Chemistry and Biology
Ryerson University